March 13, 2018

While the change in insurance co-pay terms for new policies could have some negative near-term impact, we see limited impact on RMG, given its group practice model, price transparency and peer doctor review. Maintain BUY and DCF based target price of S$1.32 by UOB Kay Hian. Share price closed at S$1.190